Aucta Pharmaceuticals Announces Launch of PYQUVI Oral Suspension for DMD Aucta Pharmaceuticals prepares to release PYQUVI, a new oral suspension for treating Duchenne muscular dystrophy, offering patients a vital treatment option.

Aucta Pharmaceuticals Announces Launch of PYQUVI Oral Suspension for DMD #United_States #Basking_Ridge #Duchenne_Muscular_Dystrophy #Aucta_Pharmaceuticals #PYQUVI